COVID-19 has changed the rules for engaging patients with chronic conditions. Some of these changes are temporary (we hope), but many look to be permanent. Several marketing and patient engagement strategies on social – born in response to the pandemic and running for the past 6 months – were so successful, many biopharma marketers have made them staples of their 2021 and 22 plans. On-demand access to medical expertise, digital-first approaches, patient activation in the home, digital adherence, and virtual events are here to stay – even in a post-vaccine world. To learn why and how, this webinar will center on 5 recent case studies that illustrate the new rules for engaging patients in social networks.

There’s no lack of need for digital transformation, obviously accelerated by COVID-19 and continuing well into the next normal. Most challenging has been the reinvention of the life science go-to-market model. Adding a new channel here or there won’t fundamentally change access and engagement. In fact, we risk overwhelming channels like email and remote detailing. There is a bigger theme and opportunity around building always-on self-service capabilities that extend commercial engagement as well as bridge into medical support. This requires significant pivots in the “push” and “pull” mix, commercial and scientific support working together, and greater considerations for next best action. This is what our panel will tackle.

Complexity of everyday operations in life sciences industry is constantly increasing. To keep up with the regulatory requirements while maintaining the quality, efficacy and safety of their products in focus, the companies have to constantly re-visit their approach to processes, technology and information. Staying flexible and agile is the key. In this webinar we will take a look into new trends, learn about the potential and opportunities of implementing integral quality management platforms that seamlessly link not only activities within QA/QC departments, but also merge them into the comprehensive process that includes R&D, manufacturing, regulatory, labeling and other internal and external stakeholders. Join us to see how to manage process dependencies (from a deviation, through CAPA, over change management all the way to variation submission), cope with the transition from the classic monolithic document centric world towards the data driven and structured environment of the future, and use the power of intelligent analytics to stay in control of your processes.

Health care expenditures continue to rise, fueled in part by an increase in the number of specialty medications that have been developed across a wide range of diseases from immunology to high cholesterol. The challenge for life science companies, payers, providers and patients is how to identify those product innovations that are going to have the greatest impact on patient outcomes at a cost that doesn’t significantly add to the financial burden of health care. Join this webcast to learn more on the integration of de-identified health claims and EHR data.

Many life science companies have undertaken a long journey to establish, expand and improve their Regulatory Information Management system landscape throughout the past years. Although much progress has been made and a well-established baseline is observed across the entire industry, there is still a journey ahead of us when it comes to the management of regulatory content.

In this webinar Frits Stulp, Managing Director of Iperion Life Sciences Consultancy and IDMP expert will give a general status update on IDMP. He will cover data model updates as well as the future data submission process according to the proposed TOM, including insights on how the current 3rd acknowledgment process will be addressed.

In June of 2020, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule that if finalized would revise how manufacturer coupons are accounted for in best price calculations. Watch this webcast for a discussion on the topic.

The media industry has changed significantly over the past five years, and marketers have more options than ever before when it comes to investing their marketing dollars. Traditional agencies and consultancies have expanded their offerings to not just serve media but measure performance too. Join AbbVie, Crossix, and Havas Media to understand the challenges that come with this approach to media measurement and optimization and learn how to implement the right frameworks to maximize the impact of your marketing investments.

Understanding the nuances of health equity and social determinants of health are imperative to pave the pathway forward for better outcomes for consumers, organizations and the health industry. Join our panel of experts to learn what racism in healthcare looks like from different perspectives, the spotlight COVID-19 placed on inequities, and how brands and marketers can be more intentional about it to drive lasting change.

The COVID-19 pandemic has presented our industry and our world with unprecedented challenges and has accelerated the need for collaboration and cooperation, especially in the healthcare realm.

In recognizing this need, MM&M’s online expo is designed to promote social interaction and engagement among participants, and foster meaningful dialogue between presenters and attendees through informative sessions and our interactive exhibit hall.

The Country’s Leading Physicians Discuss What Pharma Marketers Are Missing and How They Can Do Better

The SurvivorNet Upfront will feature prominent partner physicians on the frontlines of cancer treatment and prevention – including Dr. Nina Shah, a noted multiple myeloma specialist at UCSF, colorectal surgeon Dr. Heather Yeo from Weill Cornell and Dr. Elizabeth Comen who treats breast cancer patients and conducts research at Memorial Sloan Kettering Cancer Center.

In this webinar, Biogen, and their partner IPM.ai, will discuss how leveraging machine learning and artificial intelligence can help improve trial recruitment.

Whether it’s selecting possible location sites, expanding the list of physicians who treat the disease (vs. focusing only on a smaller subset like your target list), utilizing de-identified longitudinal claims and cutting edge machine learning techniques puts Biogen at the forefront for their clinical trial recruitment efforts.

In the wake of the COVID-19 crisis, the healthcare industry has been forced to embrace this new normal by adjusting both its mindset and its messaging in order to stay connected with patients and engaged with HCPs. In addition to anticipating patients’ constantly emerging needs, industry experts must also find ways to engage with patients and HCPs remotely, yet authentically, by adopting solutions and innovations that cater toward more personalized and pre-emptive types of care and treatment.

Join us for this pre-conference webcast to get a sneak peek into the cutting-edge educational content that our high-level speakers will be discussing during the conference, specifically some of the ways the coronavirus response has pushed the adoption and access curve for telemedicine and altered the course of healthcare communications.

As HCPs work hard to contain the spread of COVID-19, maintaining the flow of information between pharma and physicians becomes increasingly vital, with medical marketers being tasked to ensure therapeutic communication isn’t compromised.

This virtual event will provide our partners with a platform to showcase their capabilities and offerings that can be beneficial to healthcare professionals during these difficult times. MM&M’s editorial team and industry experts will discuss the impact of the COVID-19 pandemic on the healthcare industry, and where we go from here.

In this webinar Web Sun, President and Co-Founder of Komodo Health will discuss how Medical Affairs can continue to be successful during the pandemic, as well as share opportunities for how to best prepare for success in a post COVID-19 market.

With healthcare on the front lines of the COVID-19 pandemic, the ways in which we communicate have been drastically altered, and finding new ways to connect with patients and providers has become paramount. In the face of this new communication landscape, companies are looking to do more with less, embracing flexibility and the power of digital tools to keep vital health and treatment information flowing.

Within our current climate, opening the lines of communication has become more important than ever before. Companies must be quick to adapt to the “new normal” brought on by the COVID-19 pandemic or be left behind.

MM&M Convene is our way of helping our partners adapt to the drastically accelerated shift to virtual communication, by providing a platform to showcase companies’ capabilities, expertise and offerings that can be beneficial to healthcare industry professionals during these difficult times and beyond.

Pharma marketing has come a long way, however the art of managing a brand’s share of voice in this modern landscape of constrained resources and diminished in-person access to healthcare providers (HCPs) continues to be a work in progress. In response, a vast majority of marketing managers have moved from a traditional rep-centric model to non-personal promotion (NPP), with a major focus on digital advertising.

During this webinar, Becky Chidester, Dr. Destry Sulkes, Mark Truss and Nichole Davies of Wunderman Thompson Health will: unveil findings from the third annual Wunderman Thompson Health Inertia Study, discuss the steps healthcare brands can take to leverage behavioral economics and research insights to develop high-impact, personalized creative content, share how brands can use data and technology to create streams of dynamic content that expose the right messages to the right audiences at the right times to inspire action.

In this webinar, we will discuss how audience targeting is changing with today’s heightened focus on privacy. How can pharma brands serve messaging to highly qualified consumers, while preserving the privacy of patients? The panel will discuss current approaches in the marketplace and the impact of the 2020 NAI guidelines on targeted health campaigns.

Marketers need to think beyond the traditional agency of record (AOR) partnership to a model that enables teams to crowdsource creative resources, accelerating timelines and increasing the quality of work. Find out how to effectively harness the power of creative crowdsourcing.

Lesley Foster with Swiss Precision Diagnostics GmbH (SPD) provides insights on how she implemented a terminology management program that resulted in less rework and significantly improved quality of SPD’s localized deliverables.

Today, regulators are shifting from document to data-based processes, using structured content as the source format for documentation ⁠— and receiving much attention.
In this webcast, we will explore various aspects of author engagement in structured content authoring.

This webcast will provide a fresh perspective and new insights using data points from our experience and recent research.

Join us to learn the latest market trends in access management as well as innovative solutions.

In this webcast, we will discuss some of the challenges of video localization and share standard practices in the creation of video content strategies for global audiences.

In this webinar, we will review different approaches to fraud detection, the subject of diagnostic testing, and if it’s best controlled through humans or artificial intelligence.